One-year progression of erosive disease in patients with anti-citrullinated peptide antibodies and arthralgia

Kresten Krarup Keller; Jesper S Thomsen; Kristian Stengaard-Pedersen; Josephine Therkildsen; Andreas W Nielsen; Berit Schiøtz-Christensen; Lone Svendsen; Merete Graakjær; Peter M Petersen; Barbara Unger; Søren G Kjær; Bente L Langdahl; Ellen M Hauge

doi:10.1016/j.jbspin.2019.09.006

One-year progression of erosive disease in patients with anti-citrullinated peptide antibodies and arthralgia

Joint Bone Spine. 2020 Mar;87(2):181-183. doi: 10.1016/j.jbspin.2019.09.006. Epub 2019 Sep 12.

Affiliations

¹ Department of Rheumatology, Aarhus University Hospital, 8200 Aarhus N, Denmark; Diagnostic Centre, Silkeborg Regional Hospital, 8600 Silkeborg, Denmark. Electronic address: [email protected].
² Department of Biomedicine-Anatomy, Aarhus University, 8000 Aarhus C, Denmark.
³ Department of Rheumatology, Aarhus University Hospital, 8200 Aarhus N, Denmark; Department of Clinical Medicine, Aarhus University, 8200 Aarhus N, Denmark.
⁴ Department of Rheumatology, Aarhus University Hospital, 8200 Aarhus N, Denmark.
⁵ Spine Center of Southern Denmark, 5500 Middelfart, Denmark.
⁶ Lone Svendsen, Private Practice in Rheumatology, 8660 Skanderborg, Denmark.
⁷ Clinic of Rheumatology, 8000 Aarhus, Denmark.
⁸ Department of Internal Medicine, Randers Hospital, 8900 Randers, Denmark.
⁹ Department of Internal Medicine, Horsens Hospital, 8700 Horsens, Denmark.
¹⁰ Diagnostic Centre, Silkeborg Regional Hospital, 8600 Silkeborg, Denmark.
¹¹ Department of Endocrinology, Aarhus University Hospital, 8200 Aarhus N, Denmark.

PMID: 31521790
DOI: 10.1016/j.jbspin.2019.09.006

No abstract available

Keywords: Anti-citrullinated protein autoantibodies; Arthralgia; Bone erosion; High-resolution peripheral quantitative computed tomography; Rheumatoid arthritis.

Publication types

Letter

MeSH terms

Anti-Citrullinated Protein Antibodies*
Arthralgia / diagnosis
Arthralgia / etiology
Arthritis, Rheumatoid* / diagnosis
Autoantibodies
Biomarkers
Disease Progression
Humans
Peptides, Cyclic
Rheumatoid Factor

Substances

Anti-Citrullinated Protein Antibodies
Autoantibodies
Biomarkers
Peptides, Cyclic
Rheumatoid Factor